IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 7.38
0.00 (0.00%)
Apr 15, 2026, 2:53 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 6.83 million as of April 15, 2026. Its market cap has decreased by -10.61% in one year.
Market Cap
6.83M
Enterprise Value
3.48M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.38
Market Cap Chart
Since October 15, 2013, IXICO's market cap has decreased from 8.82M to 6.83M, a decrease of -22.53%. That is a compound annual growth rate of -2.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 6.83M | -37.23% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 17.56M |
| Genflow Biosciences | 11.52M |
| Cizzle Biotechnology Holdings | 9.32M |
| Oxford BioDynamics | 8.15M |
| Futura Medical | 6.92M |
| CRISM Therapeutics | 5.95M |
| OptiBiotix Health | 5.63M |
| Nuformix | 4.96M |